Prostate cancer survival and prostate cancer life expectancy are like two sides of the same coin. One is entirely dependent on the other. Each individual is unique in this world. Family history regarding a specific disease, lifestyle, dietary habits, all are contributory factors to the survival and, of course as a corollary, to his life expectancy.
It is a well established axiom that the earlier the cancer is detected, the treatment options are very clear and the survival possibilities are very encouraging. Those way even the spreading of the infection to other parts of the body (metastasis). When once the metastasis starts, the survival chances are very slim.
In general, the diagnostic skills measure the chances of prostate cancer survival. Diagnosis is conducted by two methods – staging and grading. Four successive stages have been recognized about the severity of the malaise. When the cancer is confined within the prostate, it is Stage A. Stage B denotes there are numerous cell clusters – nodules – have started forming but still confined to the prostate area. Stage C represents modules spreading locally. Stage D is the final stage when modules get transported to all parts of the body triggering metastasis.
Gleason scaling system evaluates the progress of prostate cancer. It has evolved a scale for measurement of the spreading of prostate cancer. The scales used are from 2 to 10. Up to 6 in the scale, the cancer cells are not multiplying and the chance of spreading is slim. A scale of 7 indicated aggressive cell formation and all Gleason scales from 8 to 10 pinpoints metastasis.
Are their methods to actually prevent the on setting of prostate cancer to enhance the chances of prostate cancer survival? The answer is an emphatic no. There are some choices according to researchers to reduce the risk. Diet and lifestyle choices play a vital part in reducing prostate cancer risk. Exercising in fresh air full of oxygen and eating a low-fat diet rich in fruits, vegetables and maintaining a healthy weight can also help reducing the risk
.In order to prolong prostate cancer life expectancy, different treatment options is mooted. But as per Medical Review Boards, it takes about 10 years to complete detailed studies over a broad spectrum of patients, which is a costly proposition. So researchers have taken data from the past to compare treatments. This is called a retrospective study and is not very reliable.
The development of cancer in older men (which is always the case) challenges the efficiency of treatment methods, since due to the slow-growing nature; they may not need any treatment at all if the scale of the disease is low.
Prostate cancer survival is an intricate issue. The triggering of cancer mechanism is governed by multiple factors like food habits, and lifestyle. Prostate cancer life expectancy, on the other hand, is dictated by the treatment options and the age.